The COVID-19 pandemic has reshaped the landscape of global health, revealing novel interactions between infectious diseases and chronic conditions suc…

A court in Germany has granted an injunction that will prevent MSD from distributing the new, subcutaneous version of its cancer drug Keytruda.

Signal Transduction and Targeted Therapy - Dynamic transcriptional immune landscape in response to NK-cell therapy combined with gemcitabine plus S-1 in advanced pancreatic cancer: a phase 1b/2 trial

A clinical oncology research team at the LKS Faculty of Medicine, the University of Hong Kong (HKUMed), in collaboration with the US National Cancer Institute (NCI), has developed an innovative big…

Join Keystone Symposia’s 2026 Cancer Series—4 meetings advancing cancer therapy from molecular pathways to patient-centered care through discovery and innovation.

Background Ultraviolet radiation (UVR) affects local cutaneous and systemic immunity acutely. The wavelength, pattern and intensity of UVR exposure, individual skin phototype and immune state of indiv...

A new study identifies genetic modifications that make natural killer cells more effective at destroying cancer cells. ...

The scientific community has been galvanized by the announcement of the medicine nobel prize 2025, honoring three scientists whose work fundamentally redefined our understanding of the human immune system. Mary E. Brunkow, Fred Ramsdell (both USA), and Shimon Sakaguchi (Japan) were jointly awarded the prestigious prize for their “discoveries concerning peripheral immune tolerance.” ​This groundbreaking research unveiled the crucial mechanisms that prevent our powerful immune defenses from mistakenly attacking the body’s own tissues—a condition known as autoimmunity. Their collective work identified the immune system’s ultimate “security guards”: Regulatory T-cells (Tregs), establishing a new pillar in the field of modern immunology. […]

US, Japanese Scientists Win 2025 Nobel Prize For Medicine.

A novel immunotherapy employs a nanovaccine that targets both bulk tumor cells and cancer stem cells to reduce the risk of post‑surgical recurrence and metastasis. ...

In a new study that combines synthetic biology with cancer immunotherapy, researchers have developed an engineered strain of gut-homing bacteria that stimulates potent antitumor immune responses against colorectal cancer. ...

Solid tumors are characterized by extensive extracellular matrix (ECM) remodeling prominently featuring massive collagen deposition.

This link will take you to a page that’s not on LinkedIn